Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
NYU Langone Health · New York University · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,584
total citations
- FWCI
- 34.59
- Percentile
- 100%
- References
- 27
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Reactogenicity
- Immunogenicity
- Medicine
- Tolerability
- Virology
- Vaccination
- Pandemic
- Coronavirus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.